Abstract
MDSCs are a group of cells with potent immune-suppressive activity. These cells accumulate in many pathologic conditions and play a major role in the regulation of immune responses. The nature of MDSC remains highly debatable. In cancer, most MDSCs are represented by cells with granulocytic phenotype and morphology, G-MDSC. The relationship between G-MDSCs and Neu remains unclear. In this study, we have found that G-MDSCs, from tumor-bearing, and Neu, from tumor-free, mice share a common morphology and phenotype. However, in contrast to Neu, a substantial proportion of G-MDSCs expressed M-CSFR and a CD244 molecule. Neu had significantly higher phagocytic activity, expression of lysosomal proteins, and TNF-α than corresponding G-MDSCs, which had significantly higher activity of arginase, MPO, and ROS. In contrast to G-MDSC, neither rested nor mobilized Neu suppressed T cells. G-MDSC survived 2 days in culture in the presence of GM-CSF and within 24 h, became phenotypic and functionally similar to Neu. Tumor-associated G-MDSC shared most characteristics of splenic G-MDSC, rather then Neu. These data suggest that in cancer, despite morphological and phenotypic similarities, G-MDSCs are functionally distinct from Neu and are comprised of pathologically activated precursors of Neu.
MeSH Terms
Animals
Cell Line, Tumor
Colonic Neoplasms/immunology,pathology
Disease Models, Animal
Female
Granulocytes/cytology,immunology
Immunophenotyping/methods
Melanoma/immunology,pathology
Mice
Mice, Inbred C57BL
Myeloid Cells/cytology,immunology
Phagocytosis/immunology
Skin Neoplasms/immunology,pathology
Thymoma/immunology,pathology
Thymus Neoplasms/immunology,pathology
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Youn Je-In
H. Lee Moffitt Cancer Center, Tampa, Florida 33612, USA.
Collazo Michelle
Shalova Irina N
Biswas Subhra K
Gabrilovich Dmitry I
References (27)
27 references, click to expand
-
Amplified RNA synthesized from limited quantities of heterogeneous cDNA.
Proc Natl Acad Sci U S A. 1990 Mar;87(5):1663-7
PMID: 1689846
-
Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells.
Stem Cells. 2010 Mar 31;28(3):620-32
PMID: 20073041
-
Determination of arginase activity in macrophages: a micromethod.
J Immunol Methods. 1994 Sep 14;174(1-2):231-5
PMID: 8083527
-
Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells.
J Immunol. 2008 Oct 1;181(7):4666-75
PMID: 18802069
-
Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells.
Nat Biotechnol. 2007 Aug;25(8):911-20
PMID: 17664940
-
Fine-tuning of immune responses by SLAM-related receptors.
J Leukoc Biol. 2006 Mar;79(3):417-24
PMID: 16365151
-
An integrated view of humoral innate immunity: pentraxins as a paradigm.
Annu Rev Immunol. 2010;28:157-83
PMID: 19968561
-
Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients.
Clin Cancer Res. 2009 Mar 15;15(6):2148-57
PMID: 19276286
-
HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment.
J Exp Med. 2010 Oct 25;207(11):2439-53
PMID: 20876310
-
Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells.
J Immunol. 2009 May 1;182(9):5693-701
PMID: 19380816
-
Myeloid-derived suppressor cell heterogeneity and subset definition.
Curr Opin Immunol. 2010 Apr;22(2):238-44
PMID: 20171075
-
Myeloid-derived suppressor cells: linking inflammation and cancer.
J Immunol. 2009 Apr 15;182(8):4499-506
PMID: 19342621
-
Comparison of human adult and fetal expression and identification of 535 housekeeping/maintenance genes.
Physiol Genomics. 2000 Apr 27;2(3):143-7
PMID: 11015593
-
Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes.
Cancer Res. 2009 Feb 15;69(4):1553-60
PMID: 19201693
-
Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species.
J Immunol. 2004 Jan 15;172(2):989-99
PMID: 14707072
-
Analysis of high density expression microarrays with signed-rank call algorithms.
Bioinformatics. 2002 Dec;18(12):1593-9
PMID: 12490443
-
Chemokines: novel targets for breast cancer metastasis.
Cancer Metastasis Rev. 2007 Dec;26(3-4):401-20
PMID: 17717637
-
Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity.
Blood. 2008 Apr 15;111(8):4233-44
PMID: 18272812
-
Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis.
Cancer Cell. 2008 Jan;13(1):23-35
PMID: 18167337
-
Subsets of myeloid-derived suppressor cells in tumor-bearing mice.
J Immunol. 2008 Oct 15;181(8):5791-802
PMID: 18832739
-
Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein.
J Exp Med. 2008 Sep 29;205(10):2235-49
PMID: 18809714
-
TLR4/MyD88-induced CD11b+Gr-1 int F4/80+ non-migratory myeloid cells suppress Th2 effector function in the lung.
Mucosal Immunol. 2010 Nov;3(6):578-93
PMID: 20664577
-
Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients.
Cancer Res. 2001 Jun 15;61(12):4756-60
PMID: 11406548
-
Myeloid-derived suppressor cells as regulators of the immune system.
Nat Rev Immunol. 2009 Mar;9(3):162-74
PMID: 19197294
-
Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis.
Cancer Cell. 2004 Oct;6(4):409-21
PMID: 15488763
-
A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation).
Blood. 2006 Mar 1;107(5):2112-22
PMID: 16269622
-
Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN.
Cancer Cell. 2009 Sep 8;16(3):183-94
PMID: 19732719